Published 07:28 IST, September 6th 2020
Moscow's COVID-19 death toll soars to 4,891 as Russia tests 'Sputnik V' vaccine
Russia's capital has confirmed 13 new deaths of patients infected with COVID-19 in the last 24 hours, taking the total tally of deaths to 4,891 on Saturday.
Advertisement
Russia's capital has confirmed 13 new deaths of patients infected with COVID-19 in last 24 hours, taking total tally of deaths to 4,891 on Saturday, September 6. As per reports, Moscow's COVID-19 response center said, "Ar 13 patients, who were diagsed with pneumonia and tested positive for coronavirus infection, died in Moscow".
Advertisement
Rising death toll
According to John Hopkins coronavirus tally, Russia has 1,011,987 confirmed cases of COVID-19 with death tally soaring up to 17,598. Russia's COVID-19 cases tally surpassed one million mark on September 1 after schools, colleges and or educational institutes were reopened.
According to John Hopkins University data, Russia stands fourth after United States, Brazil, and India in terms of COVID-19 caselo. country has also lifted most lockdown restrictions in majority of regions.
Advertisement
Meanwhile, preliminary results from two early-phase n-randomised trials of Russian vaccine candidate 'Sputnik V' showed major side effects over 42 days and induce antibody responses within 21 days, said study published in Lancet. leing peer-reviewed medical journal said that doctors conducted trials for two-part vaccine which contains a recombinant evirus 26 (r26) vector and a recombinant evirus 5 (r5) vector.
Advertisement
world’s first clinically approved vaccine against vel coronavirus has been manufactured by Gamaleya Research Institute in collaboration with Russian Health Ministry. Last month, Russian Health Minister Mikhail Murashko told meeting that it is one of first registered vaccines in world to prove its effectiveness and safety.
United States has been sceptical over Russian vaccine and US Health Secretary Alex Azar told a news conference that it is more essential to have a safe and effective COVID-19 vaccine than acing race. Murashko said that foreign colleagues are sensing specific competitive vants of Russian drug and are trying to express “groundless” doubts.
Advertisement
Advertisement
With ANI inputs
07:28 IST, September 6th 2020